Blue Note Therapeutics, a prescription digital therapeutics company, now offers Attune, the first cancer-specific prescription digital treatment for cancer-related mental health, to qualified Oncology Institute patients.
Attune provides self-directed tools based on established face-to-face therapies. It also features a virtual support group where cancer patients can connect whenever they wish.
Leave a Reply